Sort
15,842 grants matching “pancreatic cancer”
Autophagy regulation of prostate tumor development
$202,928Andrew M Thorburn · University Of Colorado Denver · R21 · FY2016 · CA
Anti-pancreatic tumorigenesis by inactivation of SAG/RBX2 E3 ubiquitin ligase
$202,928Yi Sun · University Of Michigan At Ann Arbor · R21 · FY2013 · CA
A Creative Integration of Omega-3 Fatty Acids into Pancreatic Cancer Chemotherapy
$202,928Zhengrong Cui · University Of Texas At Austin · R21 · FY2016 · CA
Genetic Testing For Men From Hereditary Cancer Families
$202,928Marc D Schwartz · Georgetown University · R21 · FY2015 · CA
Target Stat3 in pancreatic cancer using novel small molecule inhibitors
$202,835Jiayuh Lin · Research Inst Nationwide Children'S Hosp · R21 · FY2009 · CA
Development of Monoclonal Antibodies to Inhibit RAGE Activation in Pancreatic Cancer tumors
$202,810Estelle Leclerc · North Dakota State University · P20 · FY2019 · GM
Effects of salinomycin and binding target proteins in pancreatic cancer
$202,732Erxi Wu · North Dakota State University · P20 · FY2019 · GM
Targeting Cancer-Associated Myofibroblasts by DNA Hypomethylation
$202,676Benjamin Tycko · Columbia University Health Sciences · U54 · FY2015 · CA
Enhancement of dendritic cell vaccine efficiency against pancreatic cancer by M--
$202,620Qizhi C. Yao · Baylor College Of Medicine · R21 · FY2010 · CA
High Throughput Transcriptome Sequencing for Systematic Detection of Recurrent Tr
$202,602Chandan Kumar-Sinha · University Of Michigan At Ann Arbor · R21 · FY2011 · CA
Validation of Amplified Genes in Pancreatic Cancer
$202,600Translational Genomics Research Inst · P01 · FY2005 · CA
Altered Histidine Metabolism in Pancreatic Cancer: A Novel Metabolic Target to Enhance Gemcitabine Efficacy
$202,561Saraswathi Viswanathan · University Of Nebraska Medical Center · R21 · FY2019 · CA
PancFit: Do angiogenic biomarkers correlate with improved progression free survival in pancreatic cancer?
$202,536Keri L Schadler · University Of Tx Md Anderson Can Ctr · R21 · FY2019 · CA
The Role of miRNA-mediated RNAI in the Biology of Cancer
$202,534Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma
$202,499Michel M Ouellette · University Of Nebraska Medical Center · P50 · FY2011 · CA
Systemic Nanocurcumin for Pancreatic Cancer Therapy
$202,472Anirban Maitra · Johns Hopkins University · U54 · FY2011 · CA
GEMZAR--MECHANISMS OF CYTOTOXICITY &RADIOSENSITIZATION
$202,459University Of Michigan At Ann Arbor · R01 · FY2000 · CA
Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec Assay
$202,438David M. Lubman · University Of Michigan At Ann Arbor · R21 · FY2015 · CA
Development of ESiPSC approach for non-germline GEM modeling
$202,437Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue
$202,379Pei Wang · University Of Texas Hlth Science Center · R01 · FY2025 · CA
Tumor Macroenvironment and the Circadian Metabolic Clock
$202,284Selma Masri · University Of California-Irvine · K22 · FY2019 · CA
Tumor Macroenvironment and the Circadian Metabolic Clock
$202,284Selma Masri · University Of California-Irvine · K22 · FY2018 · CA
Tumor Macroenvironment and the Circadian Metabolic Clock
$202,284Selma Masri · University Of California-Irvine · K22 · FY2020 · CA
Fusion gene mutations as biomarkers of pancreatic cancer lymph node metastases
$202,275E Aubrey Thompson · Mayo Clinic Jacksonville · R21 · FY2010 · CA
Chemical ablation of ductal tree for breast cancer prevention
$202,275Lorenzo Sempere · Michigan State University · R21 · FY2019 · CA